RZ-629

· Rezubio Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RZ-629, covering 2025-08-21 to 2025-08-21. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RZ-629 in Healthy Subjects and T2D [Phase 1]

See pricing